Antigen aggregation decides the fate of the allergic immune response.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMC 2968749)

Published in J Immunol on December 07, 2009

Authors

Nadja Zaborsky1, Marietta Brunner, Michael Wallner, Martin Himly, Tanja Karl, Robert Schwarzenbacher, Fatima Ferreira, Gernot Achatz

Author Affiliations

1: Department of Molecular Biology, Christian Doppler Laboratory for Allergy Diagnosis and Therapy, University of Salzburg, Salzburg, Austria.

Articles citing this

Detection and analysis of unusual features in the structural model and structure-factor data of a birch pollen allergen. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 1.64

Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome. PLoS One (2011) 1.02

Response to Detection and analysis of unusual features in the structural model and structure-factor data of a birch pollen allergen. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.96

Transient dimers of allergens. PLoS One (2010) 0.92

The impact of nitration on the structure and immunogenicity of the major birch pollen allergen Bet v 1.0101. PLoS One (2014) 0.89

Fold stability during endolysosomal acidification is a key factor for allergenicity and immunogenicity of the major birch pollen allergen. J Allergy Clin Immunol (2015) 0.89

Stabilization of the dimeric birch pollen allergen Bet v 1 impacts its immunological properties. J Biol Chem (2013) 0.84

Differences in the intrinsic immunogenicity and allergenicity of Bet v 1 and related food allergens revealed by site-directed mutagenesis. Allergy (2013) 0.79

Prevention of intestinal allergy in mice by rflaA:Ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC. PLoS One (2014) 0.78

Genomic organisation of the Mal d 1 gene cluster on linkage group 16 in apple. Mol Breed (2011) 0.78

Human CD4+ T cell responses to the dog major allergen Can f 1 and its human homologue tear lipocalin resemble each other. PLoS One (2014) 0.77

Allergen hybrids - next generation vaccines for Fagales pollen immunotherapy. Clin Exp Allergy (2014) 0.77

The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals. PLoS One (2015) 0.77

Effects of autoclaving and high pressure on allergenicity of hazelnut proteins. J Clin Bioinforma (2012) 0.76

Another case of fraud in structural biology. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.75

Trial tests Austrian integrity body. Nature (2012) 0.75

Heat processing of peanut seed enhances the sensitization potential of the major peanut allergen Ara h 6. Mol Nutr Food Res (2016) 0.75

Allergenic Can f 1 and its human homologue Lcn-1 direct dendritic cells to induce divergent immune responses. J Cell Mol Med (2015) 0.75

Amb a 1 isoforms: unequal siblings with distinct immunological features. Allergy (2017) 0.75

Articles cited by this

Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63

A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol (2008) 6.78

The development of allergic inflammation. Nature (2008) 4.52

Differentiation of T regulatory cells by immature dendritic cells. J Exp Med (2001) 2.35

X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nat Struct Biol (1996) 2.25

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol (2004) 2.12

T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol (2008) 2.10

Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol (2009) 2.03

Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier. J Mol Biol (2003) 1.99

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med (1996) 1.51

Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest (2001) 1.43

TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation. J Leukoc Biol (2009) 1.31

In search for more accurate alignments in the twilight zone. Protein Sci (2002) 1.31

Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J (1998) 1.28

Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. J Leukoc Biol (2005) 1.25

Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J Allergy Clin Immunol (2009) 1.24

Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Clin Exp Allergy (2008) 1.23

Dimerization of the major birch pollen allergen Bet v 1 is important for its in vivo IgE-cross-linking potential in mice. J Immunol (2005) 1.22

The molecular basis of allergenicity. Trends Immunol (2008) 1.19

IL-6 is required for airway mucus production induced by inhaled fungal allergens. J Immunol (2009) 1.17

Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells. J Immunol (2009) 1.14

Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides. J Allergy Clin Immunol (2004) 1.11

The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy. Clin Exp Allergy (1999) 1.11

Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J Immunol (2007) 1.10

Immunotherapy of allergic disease. Adv Immunol (2004) 1.10

Isoforms of Bet v 1, the major birch pollen allergen, analyzed by liquid chromatography, mass spectrometry, and cDNA cloning. J Biol Chem (1995) 1.10

The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells. Eur J Immunol (2008) 1.09

NQ-Flipper: recognition and correction of erroneous asparagine and glutamine side-chain rotamers in protein structures. Nucleic Acids Res (2007) 1.04

Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. J Allergy Clin Immunol (2000) 1.01

Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen allergy. J Allergy Clin Immunol (2007) 1.01

High-level expression and purification of the major birch pollen allergen, Bet v 1. Protein Expr Purif (1997) 1.00

Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation. Allergy (2009) 1.00

Seven different genes encode a diverse mixture of isoforms of Bet v 1, the major birch pollen allergen. BMC Genomics (2006) 0.99

From allergen structure to new forms of allergen-specific immunotherapy. Curr Opin Immunol (2002) 0.99

Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 production. J Allergy Clin Immunol (2002) 0.97

Adjuvant potential of aggregate-forming polyglutamine domains. Vaccine (2008) 0.92

Production of interleukin-13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription-6. Immunology (2003) 0.92

Allergen structures and biologic functions: the cutting edge of allergy research. Curr Allergy Asthma Rep (2008) 0.83

Isoforms of atopic allergens with reduced allergenicity but conserved T cell antigenicity: possible use for specific immunotherapy. Int Arch Allergy Immunol (1997) 0.83

Dendritic cells in allergy. Allergy (1999) 0.83

Atopic allergy: a failure of antigen-presenting cells to properly polarize helper T cells? Am J Respir Crit Care Med (2000) 0.81

The structural requirements of epitopes with IgE binding capacity demonstrated by three major allergens from fish, egg and tree pollen. Scand J Clin Lab Invest Suppl (1991) 0.79

Modified T-cell activation pattern during specific immunotherapy (SIT) in cat-allergic patients. Clin Exp Allergy (1999) 0.79

Dendritic Cells from Spleen, Mesenteric Lymph Node and Peyer's Patch Can Induce the Production of Both IL-4 and IFN-gamma from Primary Cultures of Naive CD4(+) T Cells in a Dose-Dependent Manner. Cytotechnology (2003) 0.79

Novel approaches in immunotherapy. Clin Rev Allergy (1994) 0.78

Articles by these authors

Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci (2008) 4.32

OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain (2007) 3.35

Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell (2010) 2.96

Molecular pathways to neurodegeneration. Nat Med (2004) 2.94

Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med (2011) 2.87

Structure of the apoptotic protease-activating factor 1 bound to ADP. Nature (2005) 2.63

Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol (2003) 2.44

Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc Natl Acad Sci U S A (2008) 2.17

The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature (2008) 2.11

The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One (2008) 1.99

The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat Struct Mol Biol (2003) 1.91

Identification of small molecule inhibitors of anthrax lethal factor. Nat Struct Mol Biol (2003) 1.86

Spatiotemporal control of spindle midzone formation by PRC1 in human cells. Proc Natl Acad Sci U S A (2006) 1.73

Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J (2002) 1.66

A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses. J Biol Chem (2010) 1.55

Crystal structure of TM1367 from Thermotoga maritima at 1.90 A resolution reveals an atypical member of the cyclophilin (peptidylprolyl isomerase) fold. Proteins (2006) 1.51

From allergen genes to allergy vaccines. Annu Rev Immunol (2010) 1.46

Nomenclature and structural biology of allergens. J Allergy Clin Immunol (2006) 1.45

Novel allergens from ancient foods: Man e 5 from manioc (Manihot esculenta Crantz) cross reacts with Hev b 5 from latex. Mol Nutr Food Res (2013) 1.41

Distinct roles of secreted HtrA proteases from gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherin. J Biol Chem (2012) 1.31

Characterization of the human GARP (Golgi associated retrograde protein) complex. Exp Cell Res (2005) 1.30

S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease. J Alzheimers Dis (2010) 1.26

Epidermal langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunization. J Immunol (2007) 1.25

Crystal structure of a PIN (PilT N-terminus) domain (AF0591) from Archaeoglobus fulgidus at 1.90 A resolution. Proteins (2004) 1.17

Crystallographically mapped ligand binding differs in high and low IgE binding isoforms of birch pollen allergen bet v 1. J Mol Biol (2012) 1.13

Quinone biogenesis: Structure and mechanism of PqqC, the final catalyst in the production of pyrroloquinoline quinone. Proc Natl Acad Sci U S A (2004) 1.13

Inefficient processing of mRNA for the membrane form of IgE is a genetic mechanism to limit recruitment of IgE-secreting cells. Eur J Immunol (2006) 1.11

Three-dimensional structure of the NLRP7 pyrin domain: insight into pyrin-pyrin-mediated effector domain signaling in innate immunity. J Biol Chem (2010) 1.11

The spectrum of allergens in ragweed and mugwort pollen. Int Arch Allergy Immunol (2005) 1.10

Plant-based heterologous expression of Mal d 2, a thaumatin-like protein and allergen of apple (Malus domestica), and its characterization as an antifungal protein. J Mol Biol (2003) 1.09

Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals. Proc Natl Acad Sci U S A (2013) 1.09

Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine (2002) 1.09

Crystal structure of a tandem cystathionine-beta-synthase (CBS) domain protein (TM0935) from Thermotoga maritima at 1.87 A resolution. Proteins (2004) 1.09

The structure of the neurotoxin-associated protein HA33/A from Clostridium botulinum suggests a reoccurring beta-trefoil fold in the progenitor toxin complex. J Mol Biol (2005) 1.08

Evaluation of Nod-like receptor (NLR) effector domain interactions. PLoS One (2009) 1.08

K14 mRNA reprogramming for dominant epidermolysis bullosa simplex. Hum Mol Genet (2010) 1.08

Reshaping the Bet v 1 fold modulates T(H) polarization. J Allergy Clin Immunol (2011) 1.05

Crystal structure of acireductone dioxygenase (ARD) from Mus musculus at 2.06 angstrom resolution. Proteins (2006) 1.03

Mutational analysis of amino acid positions crucial for IgE-binding epitopes of the major apple (Malus domestica) allergen, Mal d 1. Int Arch Allergy Immunol (2005) 1.02

Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome. PLoS One (2011) 1.02

The European Union CREATE project: a model for international standardization of allergy diagnostics and vaccines. J Allergy Clin Immunol (2008) 1.01

Evolution of Crohn's disease-associated Nod2 mutations. Immunogenetics (2008) 1.01

Naturally processed T cell-activating peptides of the major birch pollen allergen. J Allergy Clin Immunol (2010) 1.00

Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. J Allergy Clin Immunol (2009) 1.00

The NLRP12 pyrin domain: structure, dynamics, and functional insights. J Mol Biol (2011) 1.00

Two novel types of O-glycans on the mugwort pollen allergen Art v 1 and their role in antibody binding. J Biol Chem (2004) 0.99

The riddle of the dual expression of IgM and IgD. Immunology (2006) 0.99

Crystal structure of the global regulatory protein CsrA from Pseudomonas putida at 2.05 A resolution reveals a new fold. Proteins (2005) 0.99

The structure of a biosynthetic intermediate of pyrroloquinoline quinone (PQQ) and elucidation of the final step of PQQ biosynthesis. J Am Chem Soc (2004) 0.98

Activation and specificity of human caspase-10. Biochemistry (2010) 0.98

Fermentation of mixed glucose-xylose substrates by engineered strains of Saccharomyces cerevisiae: role of the coenzyme specificity of xylose reductase, and effect of glucose on xylose utilization. Microb Cell Fact (2010) 0.98

Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation. Innate Immun (2011) 0.97

Response to Detection and analysis of unusual features in the structural model and structure-factor data of a birch pollen allergen. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.96

Molecular and immunological characterization of ragweed (Ambrosia artemisiifolia L.) pollen after exposure of the plants to elevated ozone over a whole growing season. PLoS One (2013) 0.95

Nitration of the pollen allergen bet v 1.0101 enhances the presentation of bet v 1-derived peptides by HLA-DR on human dendritic cells. PLoS One (2012) 0.95

Mechanisms of allergen-antibody interaction of cockroach allergen Bla g 2 with monoclonal antibodies that inhibit IgE antibody binding. PLoS One (2011) 0.94

Human placental development is impaired by abnormal human chorionic gonadotropin signaling in trisomy 21 pregnancies. Endocrinology (2007) 0.93

The role of lipid transfer proteins in allergic diseases. Curr Allergy Asthma Rep (2010) 0.93

Humoral and cellular cross-reactivity between Amb a 1, the major ragweed pollen allergen, and its mugwort homolog Art v 6. J Immunol (2011) 0.92

Biology of weed pollen allergens. Curr Allergy Asthma Rep (2004) 0.92

Crystal structure of a novel manganese-containing cupin (TM1459) from Thermotoga maritima at 1.65 A resolution. Proteins (2004) 0.92

Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus. J Virol (2010) 0.91

Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites. PLoS One (2010) 0.91

Crystal structure of an alanine-glyoxylate aminotransferase from Anabaena sp. at 1.70 A resolution reveals a noncovalently linked PLP cofactor. Proteins (2005) 0.91

The pyrroloquinoline quinone biosynthesis pathway revisited: a structural approach. BMC Biochem (2008) 0.91

Ozone affects pollen viability and NAD(P)H oxidase release from Ambrosia artemisiifolia pollen. Environ Pollut (2011) 0.91

HS1-associated protein X-1 interacts with membrane-bound IgE: impact on receptor-mediated internalization. J Immunol (2006) 0.90

The T-cell response to Amb a 1 is characterized by 3 dominant epitopes and multiple MHC restriction elements. J Allergy Clin Immunol (2010) 0.89

A new allergen from ragweed (Ambrosia artemisiifolia) with homology to art v 1 from mugwort. J Biol Chem (2010) 0.89

Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy. J Allergy Clin Immunol (2006) 0.89

Crystal structure of a ribose-5-phosphate isomerase RpiB (TM1080) from Thermotoga maritima at 1.90 A resolution. Proteins (2004) 0.89

Crystal structure of the ApbE protein (TM1553) from Thermotoga maritima at 1.58 A resolution. Proteins (2006) 0.89

Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells. Blood (2014) 0.89

Crystal structure of a glycerophosphodiester phosphodiesterase (GDPD) from Thermotoga maritima (TM1621) at 1.60 A resolution. Proteins (2004) 0.89

Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening. J Allergy Clin Immunol (2010) 0.88

Biochemical characterization and modulation of LH/CG-receptor during human trophoblast differentiation. J Cell Physiol (2007) 0.88

Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy. PLoS One (2012) 0.87

Crystal structure of an ORFan protein (TM1622) from Thermotoga maritima at 1.75 A resolution reveals a fold similar to the Ran-binding protein Mog1p. Proteins (2006) 0.87

Crystal structure of an HEPN domain protein (TM0613) from Thermotoga maritima at 1.75 A resolution. Proteins (2004) 0.87

Crystal structure of gamma-glutamyl phosphate reductase (TM0293) from Thermotoga maritima at 2.0 A resolution. Proteins (2004) 0.87

Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001. Immunobiology (2009) 0.87

Models of signal transduction through the B-cell antigen receptor. Immunology (2003) 0.87

Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. J Allergy Clin Immunol (2005) 0.86

The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitope. J Immunol (2002) 0.86